MedImmune, Inc. Q1 2006 Earnings Conference Call Transcript (MEDI)

MedImmune, Inc. (MEDI)
Q1 2006 Earnings Conference Call
April 20, 2006, 8:00 a.m. EST

Executives:

David M. Mott, Vice Chairman, CEO, and President
Lota Zoth, Senior Vice President and CFO
James F. Young, President, Research and Development
Edward M. Connor, M.D., Executive Vice President and Chief Medical Officer
R. Michael Smullen, Senior Vice President, Sales
Mark C. Twymann, Vice President and General Manager for Vaccines
Peter Vozzo, Investor Relations

Analysts:

Steven Harr, Morgan Stanley
May-kin Ho, Ph.D., Goldman Sachs & Co.
Craig Parker, Lehman Brothers
Geoffrey Porges, Sanford C. Bernstein & Co.
Mike King, Rodman and Renshaw
Ian Somaiya, Thomas Weisel Partners
Philip Nadeau, SG Cowen & Co.
Eric Ende, M.D., Merrill Lynch
Alex Silverstein, Bear, Sterns & Co.

Presentation

Operator

Good morning ladies and gentlemen and welcome to the First Quarter MedImmune Earnings Conference Call. My name is Kathy and I will be your coordinator for today. At this time, all participants are in a listen-only mode. We will be facilitating a question and answer session towards the end of today’s conference. At that time, if you wish to ask a question, please press “*